Novak Martin, Jecminek Vladimir, Pleva Leopold, Penhaker Marek, Schmidt Martin, Mimra Tomas, Kubicek Jan, Augustynek Martin
Department of Trauma Surgery, Ostrava University Hospital and Department of Disaster Medicine, Faculty of Medicine, Ostrava, Czechia.
Moravian-Silesian Region Emergency Medical Service, Ostrava, Czechia.
Front Bioeng Biotechnol. 2024 Aug 23;12:1433284. doi: 10.3389/fbioe.2024.1433284. eCollection 2024.
The methods for diagnosing compartment syndrome non-invasively remain under debate. Bioimpedance measurements offer a promising avenue in clinical practice, detecting subtle changes in organ impedance due to volume shifts. This study explores bioimpedance measurement as a novel, painless method for diagnosing compartment syndrome, potentially enabling continuous monitoring.
This work aims to develop a prototype device for non-invasive diagnosis of compartment syndrome based on bioimpedance changes and assess initial results through experiments on inanimate biological material. We assume a change in the bioimpedance value after the application of physiological solution.
Between 2018 and 2022, a prototype device for diagnosing limb compartment syndrome was collaboratively developed with the Department of Cybernetics and Biomedical Engineering at the Technical University of Ostrava, Czech Republic. This device operates by comparing bioimpedance between two compartments, one of which is pathologically affected (experiencing compartment syndrome). The Bioimpedance Analyzer for Compartment Syndrome (BACS) has been utilized to conduct measurements on inanimate biological material in laboratory settings. Two samples of duck and chicken tissue, as well as piglets, were employed for these experiments. According to the size of sample was compartment syndrome simulated by injecting 20-120 mL saline into one limb (breast) while leaving the other as a control. Invasive intramuscular pressure measurements were conducted post-saline injection using a conventional device (Stryker). Changes in bioimpedance were evaluated following saline application.
The non-invasive bioimpedance measurement instrument has been developed. It meets the safety requirements of European standard EN 60601-1. Measurement of accuracy showed minimal deviation for both channels (1.08% for the left channel and 1.84% for the right channel) when measuring on resistors. Ten measurements were conducted using the BACS prototype - two on chicken legs, two on duck breasts, two on duck legs, and four on piglets. Compartment syndrome simulation was achieved for all 10 measurements (IMP variance 31-45 mmHg). Following saline application, a notable decrease in bioimpedance was observed in the compartment simulating compartment syndrome (decrease by 12-78 Ω).
Non-invasive methods could revolutionize limb compartment syndrome diagnosis, offering advantages such as non-invasiveness and continuous monitoring of compartment swelling.
无创诊断骨筋膜室综合征的方法仍存在争议。生物阻抗测量在临床实践中提供了一条有前景的途径,可检测由于容积变化引起的器官阻抗细微变化。本研究探索将生物阻抗测量作为一种诊断骨筋膜室综合征的新型无痛方法,有可能实现连续监测。
这项工作旨在开发一种基于生物阻抗变化的无创诊断骨筋膜室综合征的原型设备,并通过对无生命生物材料进行实验来评估初步结果。我们假设在施加生理溶液后生物阻抗值会发生变化。
2018年至2022年期间,与捷克俄斯特拉发技术大学控制论与生物医学工程系合作开发了一种诊断肢体骨筋膜室综合征的原型设备。该设备通过比较两个腔室之间的生物阻抗来运行,其中一个腔室受到病理影响(患有骨筋膜室综合征)。骨筋膜室综合征生物阻抗分析仪(BACS)已被用于在实验室环境中对无生命生物材料进行测量。使用了两份鸭和鸡的组织样本以及仔猪进行这些实验。根据样本大小,通过向一个肢体(胸部)注射20 - 120 mL生理盐水来模拟骨筋膜室综合征,而另一个肢体作为对照。在注射生理盐水后,使用传统设备(史赛克)进行有创肌内压力测量。在施加生理盐水后评估生物阻抗的变化。
已开发出无创生物阻抗测量仪器。它符合欧洲标准EN 60601 - 1的安全要求。在测量电阻器时,精度测量显示两个通道的偏差最小(左通道为1.08%,右通道为1.84%)。使用BACS原型进行了十次测量——两次测量鸡腿,两次测量鸭胸,两次测量鸭腿,四次测量仔猪。所有十次测量均实现了骨筋膜室综合征模拟(肌内压变化范围为31 - 45 mmHg)。在施加生理盐水后,在模拟骨筋膜室综合征的腔室中观察到生物阻抗显著下降(下降了12 - 78Ω)。
无创方法可能会彻底改变肢体骨筋膜室综合征的诊断,具有无创性和对腔室肿胀进行连续监测等优点。